Details for Patent: 9,333,195

Summary for Patent: 9,333,195

Title:	Quinuclidine derivatives and medicinal compositions containing the same
Abstract:	Provided is a powder inhalant comprising 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy-1-(3-phenoxypropyl)-1-azoniabicyc- lo[2.2.2]octane wherein an anion X.sup.- is associated with the positive charge of the nitrogen atom and wherein X.sup.- is a pharmaceutically acceptable anion of a mono- or polyvalent acid.
Inventor(s):	Fernandez Forner; Maria Dolors (Barcelona, ES), Prat Quinones; Maria (Barcelona, ES), Buil Albero; Maria Antonia (Barcelona, ES)
Assignee:	ALMIRALL, S.A. (Barcelona, ES)
Application Number:	14/712,866
Patent Claim Types: see list of patent claims	Use; Composition; Compound;

Understanding the Scope and Claims of United States Patent 9,333,195

Introduction

United States Patent 9,333,195, titled "Quinuclidine derivatives and medicinal compositions containing the same," is a patent that delves into the realm of pharmaceuticals, specifically focusing on quinuclidine derivatives and their applications in medicinal compositions. Here, we will analyze the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

Patent Number and Publication

• The patent number is US9,333,195 B2, and it was published on May 14, 2015[4].

Inventor and Assignee

• The inventor listed is Maria Dolors Fernandez, and the patent is assigned to a specific entity, though the assignee is not explicitly mentioned in the provided sources.

Scope of the Patent

Subject Matter

• The patent pertains to quinuclidine derivatives, which are a class of compounds with potential therapeutic applications. These derivatives are described in detail, including their chemical structures, synthesis methods, and pharmacological properties[4].

Claims

• The patent includes multiple claims that define the scope of protection for the quinuclidine derivatives and the medicinal compositions containing them. Here are some key aspects of the claims:
  • Compound Claims: These claims specify the chemical structures of the quinuclidine derivatives, including various substituents and modifications that are covered under the patent.
  • Method Claims: These claims cover the methods of synthesizing the quinuclidine derivatives, which are crucial for reproducing the compounds.
  • Composition Claims: These claims pertain to the medicinal compositions that include the quinuclidine derivatives, outlining the formulations and uses of these compositions[4].

Claim Analysis

Claim Structure

• The claims are structured to provide broad protection while also being specific enough to distinguish the inventions from prior art. This includes independent claims that define the core inventions and dependent claims that further limit the scope of the independent claims.

Claim Scope Concepts

• Using patent analytics tools, such as those described by Schwegman, the claims can be categorized by scope concepts. This helps in understanding the breadth of protection and identifying gaps or opportunities in the patent landscape. For example, the scope concepts might include the type of quinuclidine derivative, the method of synthesis, and the specific therapeutic application[3].

Patent Landscape

Related Patents and Prior Art

• The patent is part of a larger family of patents related to quinuclidine derivatives and medicinal compositions. It is a continuation of several earlier applications, indicating a long-standing research and development effort in this area[1][4].

Competitive Landscape

• The competitive landscape in pharmaceutical patents is highly dynamic. The USPTO's Patent Claims Research Dataset can provide insights into the trends and scope of patents in this field. For instance, analyzing the dataset can reveal how many patents are granted in the pharmaceutical sector, the types of claims that are most common, and the dependency relationships between claims[5].

Trends and Implications

Industry Trends

• The pharmaceutical industry is characterized by intense innovation and patent activity. The increase in patent filings and grants in this sector reflects the ongoing research and development in new therapeutic agents and formulations.

Legal and Regulatory Environment

• The legal environment for pharmaceutical patents is complex, with ongoing debates about patent scope, claim construction, and infringement. The USPTO's guidelines and court decisions, such as those related to design patents in cases like Apple v. Samsung, can influence how claims are interpreted and enforced[2].

Practical Applications and Future Directions

Research and Development

• The quinuclidine derivatives covered by this patent have potential therapeutic applications, such as treating various diseases. The medicinal compositions containing these derivatives can be further developed and tested for efficacy and safety.

Commercialization

• For companies looking to commercialize these medicinal compositions, understanding the patent claims and scope is crucial. Patent analytics can help in identifying whether the current claims provide adequate protection and where there might be gaps or opportunities for further innovation[3].

Key Takeaways

• Patent Scope: The patent covers specific quinuclidine derivatives, their synthesis methods, and medicinal compositions containing these derivatives.
• Claim Structure: The claims are structured to provide broad yet specific protection, including independent and dependent claims.
• Patent Landscape: The patent is part of a larger family of related patents and is influenced by industry trends and legal environments.
• Practical Applications: The quinuclidine derivatives have potential therapeutic applications, and understanding the patent claims is essential for commercialization.

FAQs

1. What is the main subject matter of United States Patent 9,333,195?

   • The main subject matter is quinuclidine derivatives and medicinal compositions containing these derivatives.

2. Who is the inventor listed on the patent?

   • The inventor listed is Maria Dolors Fernandez.

3. What types of claims are included in the patent?

   • The patent includes compound claims, method claims, and composition claims.

4. How can patent analytics help in understanding this patent?

   • Patent analytics can help in categorizing claims by scope concepts, identifying gaps or opportunities, and determining the value of the patent claims.

5. What is the significance of the patent in the pharmaceutical industry?

   • The patent reflects ongoing research and development in new therapeutic agents and formulations, contributing to the dynamic landscape of pharmaceutical innovation.

Sources

1. United States Patent and Trademark Office. US10588895.pdf.
2. Quarles & Brady LLP. Recent Trends in Article of Manufacture of Design Claims: A Modern Digital Popularity Contest.
3. Schwegman, Lundberg & Woessner, P.A. Patent Analytics.
4. Google Patents. US9333195B2 - Quinuclidine derivatives and medicinal compositions containing the same.
5. United States Patent and Trademark Office. Patent Claims Research Dataset.

Drugs Protected by US Patent 9,333,195

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 9,333,195

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Spain	9901580	Jul 14, 1999

International Family Members for US Patent 9,333,195

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1200431		C300573	Netherlands
European Patent Office	1200431		CA 2013 00002	Denmark
European Patent Office	1200431		PA2013001	Lithuania